Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    expedition2
Show Display Options
Rank Status Study
1 Recruiting A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Conditions: Hepatitis C Virus Infection;   Human Immunodeficiency Virus Infection;   Chronic Hepatitis C;   Compensated Cirrhosis and Non-cirrhotics
Intervention: Drug: ABT-493/ABT-530
2 Completed Effect of LY2062430 on the Progression of Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: LY2062430;   Drug: Placebo

Indicates status has not been verified in more than two years